Pure Global

Myoglobin - India CDSCO Medical Device Registration

Myoglobin is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2021/000365_f4504a8006fe2e24718863b0b174767a_c1349d0b85e90b202901c1a90a7e3209. This device is marketed under the brand name AFIAS Infliximab . The license holder is BODITECH MED INDIA PRIVATE LIMITED, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Myoglobin
UID: IMP/IVD/2021/000365_f4504a8006fe2e24718863b0b174767a_c1349d0b85e90b202901c1a90a7e3209

Brand Name

AFIAS Infliximab

Device Class

Class B

Approving Authority

CDSCO

Product Information

AFIAS Myoglobin is a fluorescence Immunoassay (AFIAS Infliximab ) for the quantitative determination of Myoglobin in human whole blood/serum/plasma. It is useful as an aid in management and monitoring of acute myocardial infarction (AFIAS Infliximab )

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing